DSpace Repository

"OSTEOARTRIT KASALLIGIDA SIMPTOMSIZ GIPERURIKEMIYANING VA METABOLIK JIGAR YOG‘ KASALLIGINING AHAMIYATI"

Show simple item record

dc.contributor.author Miraxmedova Xilola To'xtasinovna, Nizametdinova Ulugoy Jaminovna, Saidrasulova Gulizebo Baxtiyor qizi
dc.date.accessioned 2025-05-23T04:34:26Z
dc.date.available 2025-05-23T04:34:26Z
dc.date.issued 2025
dc.identifier.issn 2181-7812
dc.identifier.uri http://repo.tma.uz/xmlui/handle/1/1483
dc.description.abstract Objective: To study the significance of metabolic fatty liver disease and asymptomatic hyperuricemia in osteoarthritis. Material and methods: The study included 70 patients aged 45 to 75 years with a confirmed diagnosis of osteoarthritis of the knee and hip joints, admitted for treatment to the rheumatology and cardiorheumatology departments of the multidisciplinary clinic of the Tashkent Medical Academy in 2024. The duration of the disease was on average from 2 to 10 years. Results: Of the total number of patients, 78.6% suffered from gonarthrosis of the knee joints, 21.4% - arthrosis of the hip joint. The average pain score on the WOMAC scale was 13.2±1.35, numbness - 4.20±2.26, functional impairment - 43.8±12.3. Conclusions: Osteoarthritis is a leading cause of morbidity, disability and loss of productivity worldwide. Osteoarthritis is associated with a number of systemic diseases, such as obesity, cardiovascular diseases, type 2 diabetes mellitus, metabolic syndrome. en_US
dc.language.iso other en_US
dc.publisher Toshkent tibbiyot akademiyasi axborotnomasi en_US
dc.subject osteoarthritis, metabolic syndrome, asymptomatic hyperuricemia, uric acid, metabolic fatty liver disease. en_US
dc.title "OSTEOARTRIT KASALLIGIDA SIMPTOMSIZ GIPERURIKEMIYANING VA METABOLIK JIGAR YOG‘ KASALLIGINING AHAMIYATI" en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account